Begley CG - Search Results

1

Erythropoietin receptor in ovarian cancer cells - Letter.

Swift SE, Elliott S, Sinclair AM, Begley CG. Swift SE, et al. Among authors: begley cg. Mol Cancer Ther. 2010 Apr;9(4):1070-1; author reply 1071. doi: 10.1158/1535-7163.MCT-09-0439. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371727 No abstract available.

2

Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients.

Sinclair AM, Todd MD, Forsythe K, Knox SJ, Elliott S, Begley CG. Sinclair AM, et al. Among authors: begley cg. Cancer. 2007 Aug 1;110(3):477-88. doi: 10.1002/cncr.22832. Cancer. 2007. PMID: 17582631 Free article. Review.

3

Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells.

Sinclair AM, Coxon A, McCaffery I, Kaufman S, Paweletz K, Liu L, Busse L, Swift S, Elliott S, Begley CG. Sinclair AM, et al. Among authors: begley cg. Blood. 2010 May 27;115(21):4264-72. doi: 10.1182/blood-2009-10-248666. Epub 2010 Feb 2. Blood. 2010. PMID: 20124513 Free article.

4

Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.

Elliott S, Busse L, McCaffery I, Rossi J, Sinclair A, Spahr C, Swift S, Begley CG. Elliott S, et al. Among authors: begley cg. J Immunol Methods. 2010 Jan 31;352(1-2):126-39. doi: 10.1016/j.jim.2009.10.006. Epub 2009 Nov 1. J Immunol Methods. 2010. PMID: 19887071

5

Lack of expression and function of erythropoietin receptors in the kidney.

Elliott S, Busse L, Swift S, McCaffery I, Rossi J, Kassner P, Begley CG. Elliott S, et al. Among authors: begley cg. Nephrol Dial Transplant. 2012 Jul;27(7):2733-45. doi: 10.1093/ndt/gfr698. Epub 2011 Dec 13. Nephrol Dial Transplant. 2012. PMID: 22167585

6

Anti-Epo receptor antibodies do not predict Epo receptor expression.

Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. Elliott S, et al. Among authors: begley cg. Blood. 2006 Mar 1;107(5):1892-5. doi: 10.1182/blood-2005-10-4066. Epub 2005 Oct 25. Blood. 2006. PMID: 16249375 Free article.

7

Absence of functional EpoR expression in human tumor cell lines.

Swift S, Ellison AR, Kassner P, McCaffery I, Rossi J, Sinclair AM, Begley CG, Elliott S. Swift S, et al. Among authors: begley cg. Blood. 2010 May 27;115(21):4254-63. doi: 10.1182/blood-2009-10-248674. Epub 2010 Feb 2. Blood. 2010. PMID: 20124514 Free article.

8

Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.

Patterson SD, Rossi JM, Paweletz KL, Fitzpatrick VD, Begley CG, Busse L, Elliott S, McCaffery I. Patterson SD, et al. Among authors: begley cg. PLoS One. 2015 Mar 25;10(3):e0122149. doi: 10.1371/journal.pone.0122149. eCollection 2015. PLoS One. 2015. PMID: 25807104 Free PMC article.

9

Kinetics of haematopoietic recovery after dose-intensive chemo/radiotherapy in mice: optimized erythroid support with darbepoetin alpha.

Hartley C, Elliott S, Begley CG, McElroy P, Sutherland W, Khaja R, Heatherington AC, Graves T, Schultz H, Del Castillo J, Molineux G. Hartley C, et al. Among authors: begley cg. Br J Haematol. 2003 Aug;122(4):623-36. doi: 10.1046/j.1365-2141.2003.04467.x. Br J Haematol. 2003. PMID: 12899718 Free article.

10

An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors.

Sánchez M, Göttgens B, Sinclair AM, Stanley M, Begley CG, Hunter S, Green AR. Sánchez M, et al. Among authors: begley cg. Development. 1999 Sep;126(17):3891-904. doi: 10.1242/dev.126.17.3891. Development. 1999. PMID: 10433917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page